Leukemia is a malignancy of developing white blood cells in the bone marrow (BM), leukocytes. Recent studies have shown that targeting novel specific antigens expressed on the surface of leukemic cells, such as CD19, CD20, and CD22 with novel monoclonal antibodies is a promising approach.
- New monoclonal antibodies: design and targets
- List of promising leukemia-associated molecules for direct targeting
- Potential leukemia targets